5-Year Overall Survival and Progression-Free Survival in Multiple Myeloma by Line of Treatment from the French Hematologic Malignancy Registry
Abstract
Authors
M Mounier S Gauthier M Mayandié X Troussard A Monnereau C Guilhaume F Suzan C Blachier-Poisson N Despiegel